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The risk of cutaneous malignant melanoma (CMM) is strongly associated with total number of nevi. Scanty
information is available on the association between CMM at a specific anatomical site and number of nevi at the
same site. We analyzed data from a case–control study conducted in Italy between 1992 and 1994, on 542 cases of
CMM and 538 hospital controls. Cases and controls were examined by trained dermatologists who counted the
number of melanocytic nevi. We derived multivariate odds ratios (ORs) and 95% confidence intervals (95% CIs)
of site-specific risk of CMM for high versus low number of nevi at the corresponding site. The ORs of CMM for
the highest versus the lowest tertile of number of nevi at the corresponding site was 1.4 (95% CIs: 0.7–2.8) at face
and neck, 2.3 (95% CIs: 1.1–4.9) at anterior trunk, 4.9 (95% CIs: 2.9–8.4) at posterior trunk, 2.9 (95% CIs: 1.2–6.6) at
upper limbs and 5.0 (95% CIs: 2.9–8.5) at lower limbs. In a case–case analysis, comparing CMM cases at a specific
site and CMM cases at all other sites, the only excess risk was found for the posterior trunk, the ORs being 2.1
(95% CIs: 1.2–3.6) for the highest versus the lowest tertile of number of nevi. Our data do not support the
hypothesis of a specific effect of nevi at each single anatomical site.
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INTRODUCTION
Cutaneous malignant melanoma (CMM) is strongly asso-
ciated with total number of nevi. A meta-analysis including
data on 46 studies published until 2002 reported that both
total number of common nevi and atypical nevi were
important and independent risk factors for melanoma, the
pooled relative risks of melanoma being 6.89 for high
(101–120) versus low (o15) number of common melanocytic
nevi, and 6.36 for 5 vs 0 atypical nevi (Gandini et al., 2005).
However, scanty information is available on the relation
between CMM at a specific site and number of nevi at the
corresponding site (Holman and Armstrong, 1984; Green et al.,
1985; Swerdlow et al., 1986; Bain et al., 1988; Weinstock
et al., 1989; Bataille et al., 1998; Whiteman et al., 2003).
In a multicentric hospital-based case–control study con-
ducted in Germany, Switzerland, and Austria based on 278
patients with melanoma and 278 controls, matched for age
and sex, the risk of melanoma on the trunk and on the legs
was best predicted by number of nevi on the corresponding
sites, but the study did not unequivocally support a site-
specific risk (Rieger et al., 1995).
A population-based case–control study including 548
newly diagnosed CMM cases and 494 controls (Caucasian
Connecticut residents) collected information on risk factors
by anatomical site in the arms and the back (Chen et al.,
1996). No relation was found between naevus count and risk
of melanoma on these sites. The study also reported that
gender was the only risk factor that affected the risk of
melanoma across anatomical sites (Chen et al., 1996), men
having higher risk for melanoma on the trunk and women on
the limbs.
Another hospital-based case–control study from southern
Spain (Rodenas et al., 1997), including 116 CMM cases and
116 controls, analyzed the risk of CMM at several sites (face
and neck, chest and abdomen, back, arms, and palms and
hands) and reported that the site-specific risk of CMM was
strongly associated with the number of melanocytic nevi on
the corresponding sites, especially among patients with
superficial spreading melanoma subtype. The study did not
report which were the most strongly associated sites.
In order to assess and quantify the site-specific association
between risk of CMM and number of nevi, we analyzed data
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from a multicentric case–control study conducted in Italy
(Naldi et al., 2000, 2005).
RESULTS
Whereas CMM on the limbs was more frequent in women
(upper 72.8% and lower limbs 82.5%), CMM on the trunk
was more frequent in men (anterior 64.6% and posterior
trunk 63.0%). CMM at face and neck was more frequent at
older ages for both sexes, while CMM at anterior and
posterior trunk was more frequent in younger women (o40
years) (Table 1).
In both genders, mean number of nevi among cases
was higher than among controls for each site considered
(Table 2).
In order to quantify the association between number of
nevi at a specific site and risk of CMM at each anatomical
site, we derived the multivariate odds ratios (ORs) of site-
specific risk of CMM for approximate tertiles of number of
nevi on each anatomical site. For CMM on face and neck, the
highest association was observed with number of nevi on
lower limbs, but direct associations were found with number
of nevi at other sites too. The risk of CMM on the anterior
trunk was associated with number of nevi on all anatomical
sites, and the strongest associations were found for number of
nevi on the limbs: the ORs for CMM on the anterior trunk
were 2.89 for X6 nevi on lower limbs and 2.84 for X5 nevi
on the upper limbs. Likewise, the number of nevi on the
posterior trunk was the best predictor of the risk of CMM on
the posterior trunk, the ORs being 4.92 for X6 nevi. Risk of
CMM at upper limbs was strongly associated with number of
nevi on lower limbs (ORs¼5.01) and, less strongly on
posterior trunk and upper limbs. Number of nevi at lower
limbs was the best predictor for risk of CMM at lower limbs
and the ORs for X6 nevi was 4.99. Number of nevi at lower
limbs was also the best predictor of the risk of CMM at all
sites, and the ORs for X6 nevi compared to 0 was 3.80
(Table 3).
The previous analyses on the risk of CMM at different sites
were repeated in a case–case analysis comparing cases of
CMM at a specific site with cases of CMM at different sites
according to number of nevi at the specific site considered.
Only CMM at posterior trunk was significantly associated
Table 1. Distribution1 of 542 cases of CMM and 538 controls by gender, age group, and anatomical site of CMM,
Italy 1992–1994
Men Women
Age group (years) Age group (years)
Anatomical site o40 40–49 50–59 60–69 X70 Total o40 40–49 50–59 60–69 X70 Total
Face/neck 6 3 5 12 10 36 4 4 12 9 16 45
Anterior trunk 10 10 10 8 4 42 10 3 4 4 2 23
Posterior trunk 16 23 26 13 19 97 20 9 14 9 5 57
Upper limbs 3 2 1 6 2 14 5 12 9 4 4 34
Lower limbs 7 3 3 11 8 32 26 29 34 33 29 151
Controls 49 36 45 56 44 230 70 57 64 61 56 308
1Information on site was missing for 11 cases.
Table 2. Mean number of melanocytic nevi and SE by anatomical site and gender for cases of CMM and controls,
Italy 1992–1994
Men Women
Cases Controls Cases Controls
Anatomical site Mean SE Mean SE Mean SE Mean SE
Whole surface 25.8 2.2 12.6 1.1 20.4 1.5 11.3 1.0
Face/neck 2.0 0.3 1.1 0.1 2.3 0.3 1.5 0.2
Anterior trunk 5.5 0.5 2.9 0.3 2.9 0.2 1.8 0.2
Posterior trunk 7.4 0.6 3.7 0.4 4.2 0.3 2.7 0.3
Upper limbs 5.3 0.6 2.5 0.3 5.3 0.5 3.0 0.3
Lower limbs 5.6 0.9 2.4 0.3 5.8 0.6 2.3 0.3
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Table 3. Odds ratios1 and 95% CIs for CMM at different anatomical locations by number of nevi: comparison with
controls
CMM site
Approximate tertiles of number
of nevi by site Face/neck Anterior trunk Posterior trunk Upper limbs Lower limbs All sites
Face/neck
02 1 1 1 1 1 1
1–2 1.01 (0.56–1.84) 0.81 (0.41–1.61) 1.02 (0.64–1.65) 0.80 (0.38–1.66) 1.08 (0.71–1.65) 0.99 (0.74–1.33)
X3 1.38 (0.68–2.80) 1.70 (0.84–3.43) 2.15 (1.30–3.55) 1.04 (0.43–2.50) 1.55 (0.95–2.52) 1.65 (1.17–2.31)
Anterior trunk
02 1 1 1 1 1 1
1–3 1.27 (0.70–2.32) 1.50 (0.72–3.13) 1.47 (0.86–2.51) 1.00 (0.47–2.13) 1.09 (0.71–1.67) 1.21 (0.89–1.64)
X4 1.95 (0.90–4.20) 2.32 (1.09–4.90) 4.36 (2.49–7.62) 1.56 (0.64–3.78) 2.02 (1.19–3.44) 2.54 (1.77–3.65)
Posterior trunk
0–12 1 1 1 1 1 1
2–5 1.98 (1.07–3.65) 1.04 (0.51–2.09) 1.70 (1.02–2.84) 1.07 (0.47–2.43) 0.92 (0.60–1.40) 1.19 (0.88–1.60)
X6 3.26 (1.50–7.09) 2.28 (1.11–4.68) 4.92 (2.87–8.42) 3.27 (1.42–7.53) 2.16 (1.28–3.67) 3.00 (2.09–4.31)
Upper limbs
02 1 1 1 1
1–4 1.64 (0.90–3.01) 1.84 (0.90–3.78) 1.77 (1.09–2.90) 1.56 (0.71–3.39) 1.67 (1.08–2.59) 1.63 (1.21–2.21)
X5 2.80 (1.37–5.74) 2.84 (1.37–5.91) 2.97 (1.75–5.04) 2.85 (1.24–6.56) 2.78 (1.68–4.61) 2.69 (1.90–3.80)
Lower limbs
02 1 1 1 1 1 1
1–5 2.06 (1.12–3.80) 1.46 (0.75–2.85) 1.28 (0.81–2.02) 1.41 (0.65–3.06) 1.42 (0.92–2.19) 1.44 (1.08–1.93)
X6 5.32 (2.40–11.80) 2.89 (1.36–6.12) 3.60 (2.05–6.33) 5.01 (2.11–11.86) 4.99 (2.92–8.53) 3.80 (2.61–5.54)
Total
0–62 1 1 1 1 1 1
7–21 2.06 (1.10–3.87) 1.47 (0.73–2.97) 1.78 (1.07–2.98) 1.67 (0.78–3.59) 1.82 (1.18–2.80) 1.69 (1.25–2.30)
X22 3.97 (1.88–8.41) 2.54 (1.23–5.22) 5.15 (3.01–8.79) 3.36 (1.42–7.94) 3.21 (1.90–5.42) 3.50 (2.45–5.00)
1Adjusted for sex, age, education, body mass index, eye, hair and skin color, solar lentigines, propensity to sunburn, sunburn episodes, and tobacco smoking.
2Reference category.
Significant ORs are given in bold.
Table 4. Odds ratios1 and 95% CIs for CMM at specific anatomical locations by number of nevi: comparison with
cases of CMM at other sites
CMM site
Approximate tertiles of
number of nevi2 Face/neck Anterior trunk Posterior trunk Upper limbs Lower limbs
I3 1 1 1 1 1
II 1.15 (0.61–.15) 1.31 (0.60–2.87) 1.50 (0.88–2.55) 0.87 (0.40–1.90) 1.12 (0.68–1.84)
III 1.06 (0.52–2.17) 0.95 (0.43–2.09) 2.07 (1.21–3.56) 0.91 (0.40–2.10) 1.17 (0.68–2.01)
1Adjusted for sex, age, education, body mass index, eye, hair and skin color, solar lentigines, propensity to sunburn, sunburn episodes, and tobacco smoking.
2Number of nevi counted on the same site of CMM.
3Reference category.
Significant ORs are given in bold.
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with number of nevi on the corresponding site, the ORs for
CMM being 2.07 for X6 nevi compared to p1 (Table 4).
DISCUSSION
Our study confirmed the effect of total number of nevi on the
risk of CMM, but did not show a site-specific association for
all sites considered, except for posterior trunk, where the risk
of CMM can be associated not only with common nevi
(42 mm), but particularly with atypical nevi which are more
likely present in the trunk than in other anatomical sites
(Rieger et al., 1995). In our study, atypical nevi (46 mm)
were more prevalent on the trunk than in other sites both
in men and in women. Thus, the mean percentage of site-
specific number of atypical nevi among male controls was
29.1% (SE¼5.3%) on the anterior trunk and 49.5%
(SE¼ 6.0%) on the posterior trunk. Corresponding values
for female controls were 28.3% (SE¼ 4.4%) and 23.6%
(SE¼ 4.0%), respectively. In contrast with Rieger et al.
(1995), we found a relatively higher mean percentage of
atypical nevi on the face and neck in women (22.4%) than in
men (10.8%).
A previous study suggested that the site-specific associa-
tion between CMM risk and number of nevi was stronger for
superficial spreading melanoma subtype (Rodenas et al.,
1997): we therefore repeated the analysis in the subset of
superficial spreading melanoma cases, but we did not find
any site-specific association.
Whiteman et al. (2003), in a study from Queensland,
Australia, based on 231 cases of invasive superficial
spreading melanoma on the trunk, and face and neck and
75 lentigo malignant melanoma, proposed different etiologi-
cal patterns for cutaneous melanoma occurring on different
body sites according to sun exposure and individual tendency
to develop nevi. Among subjects with low number of nevi
and frequent exposure to sunlight, melanomas were more
likely to arise on the head and neck, while among people
with high susceptibility to nevi, little sun exposure was
required to develop melanoma, and melanomas were more
likely to arise in sites with high density of nevi, like the trunk
(Whiteman et al., 2003). Accordingly, in our study, we found
a strong correlation between total number of nevi and risk of
CMM on the trunk. However, we also found a strong
correlation with CMM on the face and neck. Moreover, the
proportion of cases with CMM on face and neck did not vary
across strata of total number of nevi, both for men and
women. The apparent discrepancies between the two studies
could be in part due to the different locations where the
studies were conducted (Australia and Italy), whose popula-
tions differ in terms of risk factors for CMM, including in
particular sun exposure.
The main strength of this study is that cases and controls
were examined by trained dermatologists to assess pigmen-
tary traits and to count melanocytic nevi. Moreover,
participation rate was almost complete, and the catchment
areas for cases and controls were comparable. Cases were
not selected according to the anatomical site of CMM, but
were consecutive patients of each center, likely reflecting the
real body distribution of CMM in the Italian population. Thus,
number of cases in our dataset varied considerably across
various body sites (from 48 for upper limbs to 183 for lower
limbs), which implies that the statistical power differed by
body sites. With reference to potential information bias, the
interviews were conducted in the same setting for cases and
controls, and the hospital setting should improve the
comparability of recall between the two groups. Further,
careful adjustment was made for the strongest risk determi-
nants, including pigmentary traits, history of sunburns, and a
number of other potentially relevant lifestyle covariates.
Thus, it is unlikely that the present results are substantially
influenced by selection and information bias, or confounding.
In conclusion, our data did not support the hypothesis
of a specific effect of nevi at each single anatomical site,
with the exception of posterior trunk. Total count of
melanocytic nevi may be a general risk indicator and
melanocytic nevi by themselves may not be an important
precursor to CMM.
MATERIALS AND METHODS
A case–control study on CMM was conducted within the framework
of the Italian Group for Epidemiologic Research in Dermatology
(GISED) between 1992 and 1994 in 27 centers, 16 in the North and
11 in the South of Italy (Naldi et al., 2000, 2005). Cases were 542
consecutive patients (226 males and 316 females; median age 54
years, range 15–87) with incident, histologically confirmed invasive
CMM information on anatomical site was missing for 11 cases.
Approximately 1% of cases had been excluded because of a
previous diagnosis of a primary malignant melanoma. Controls were
538 patients (230 males and 308 females; median age 54 years,
range 15–92) of similar age and gender distributions as cases,
admitted to the same hospitals of cases for non-dermatological and
non-neoplastic diseases. Of controls, 30% were admitted for acute
surgical and gynecologic conditions, 23% had acute medical
disorders, 12% had traumatic or other orthopedic conditions, and
35% had other illnesses, such as disorders of the ear, nose, throat, or
teeth. Of cases and controls, o1% refused to participate. Data
collection was approved by the medical directors of the institutions
and the consultants of the wards involved, and informed consent was
obtained by subjects interviewed.
Trained interviewers administered a structured questionnaire to
cases and controls, including information on socio-demographic
characteristics, anthropometric measures, personal pigmentary
phenotype, lifetime history of sun exposure, and smoking habit.
Cases and controls were also examined by trained dermatologists
who counted the number of melanocytic nevi and made judgments
on pigmentary traits according to standardized criteria. Nevi 42 and
46 mm in diameter were counted over the whole body surface
excluding the genitalia and scalp area. A simple instrument, called a
‘‘nevometer,’’ was used to rapidly assess the diameter (2 and 6 mm).
A photographic atlas of nevi was used to facilitate judgments.
Concordance of nevus counts among assessors and within each
assessor in two independent trials was evaluated and judged to be
satisfactory with both intra- and interobserver intraclass correlation
values not lower than 0.75. Common nevi had a diameter of up to
6 mm. Atypical nevi had a diameter 46 mm, lacking features of
congenital nevi.
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For the present analysis, CMM cases were grouped according to
the anatomical site of the neoplasm in five different locations (face/
neck, anterior and posterior trunk, upper and lower limbs).
ORs for CMM at different sites by number of common nevi
(42 mm) were estimated by unconditional multiple logistic regres-
sion models (Breslow and Day, 1980), after allowance for age, sex,
education, body mass index, history of sunburns, propensity to
sunburn, number of solar lentigines, skin, hair and eye color, and
tobacco smoking.
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